Matches in Nanopublications for { ?s ?p "[The majority of the observed loci do not overlap with coding sequences; however, several observed genomic loci overlap with known cancer genes including RET in brain cancers, ERBB2 in renal cell carcinomas, and DCC in ovarian cancers, all of which have not been previously associated with germline changes in cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- assertion description "[The majority of the observed loci do not overlap with coding sequences; however, several observed genomic loci overlap with known cancer genes including RET in brain cancers, ERBB2 in renal cell carcinomas, and DCC in ovarian cancers, all of which have not been previously associated with germline changes in cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The majority of the observed loci do not overlap with coding sequences; however, several observed genomic loci overlap with known cancer genes including RET in brain cancers, ERBB2 in renal cell carcinomas, and DCC in ovarian cancers, all of which have not been previously associated with germline changes in cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The majority of the observed loci do not overlap with coding sequences; however, several observed genomic loci overlap with known cancer genes including RET in brain cancers, ERBB2 in renal cell carcinomas, and DCC in ovarian cancers, all of which have not been previously associated with germline changes in cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The majority of the observed loci do not overlap with coding sequences; however, several observed genomic loci overlap with known cancer genes including RET in brain cancers, ERBB2 in renal cell carcinomas, and DCC in ovarian cancers, all of which have not been previously associated with germline changes in cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1260389.RAKfthJoJRQockaz1Ku0ZFYU0PKCWzrGy-0ND4KRDB3AE130_assertion description "[The majority of the observed loci do not overlap with coding sequences; however, several observed genomic loci overlap with known cancer genes including RET in brain cancers, ERBB2 in renal cell carcinomas, and DCC in ovarian cancers, all of which have not been previously associated with germline changes in cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260389.RAKfthJoJRQockaz1Ku0ZFYU0PKCWzrGy-0ND4KRDB3AE130_provenance.
- NP1260388.RAwEa16BVsc-34RpkDE0dJL0-COvXe2bVaK1fjEOVSmok130_assertion description "[The majority of the observed loci do not overlap with coding sequences; however, several observed genomic loci overlap with known cancer genes including RET in brain cancers, ERBB2 in renal cell carcinomas, and DCC in ovarian cancers, all of which have not been previously associated with germline changes in cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260388.RAwEa16BVsc-34RpkDE0dJL0-COvXe2bVaK1fjEOVSmok130_provenance.
- NP1260390.RAxUQhJum_oGvjkYQqrh0UV49GKVnSs6VSRR31y1aH5d4130_assertion description "[The majority of the observed loci do not overlap with coding sequences; however, several observed genomic loci overlap with known cancer genes including RET in brain cancers, ERBB2 in renal cell carcinomas, and DCC in ovarian cancers, all of which have not been previously associated with germline changes in cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260390.RAxUQhJum_oGvjkYQqrh0UV49GKVnSs6VSRR31y1aH5d4130_provenance.